Cargando…
Blocking of The Prostaglandin E2 Receptor as a Therapeutic Strategy for Treatment of Breast Cancer: Promising Findings in a Mouse Model
OBJECTIVE: The study aimed to investigate the anticancer effect of E-prostanoid receptor 1 (EP1) antagonist, SC19220, alone or in combination with the COX-2 inhibitor Celecoxob(CXB)(®) in mice bearing solid Ehrlich carcinoma (SEC). METHODS: The tumors were induced in 40 female mice, which were divid...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
West Asia Organization for Cancer Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930950/ https://www.ncbi.nlm.nih.gov/pubmed/36444589 http://dx.doi.org/10.31557/APJCP.2022.23.11.3763 |